By Drug Target Review2025-12-16T08:30:02
New research suggests cannabis compounds CBD and THC could offer a new approach to treating ovarian cancer.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2026-03-25T15:00:00 2026-03-25T16:00:00
Sponsored by Yokogawa
2023-01-06T10:25:33
Sponsored by Leica Microsystems
2023-01-05T14:41:33
Sponsored by Cell Signaling Technology
2023-05-18T10:39:07
Sponsored by BPS Bioscience
2024-02-01T11:52:50
Sponsored by Leica Microsystems
2023-03-08T16:29:20
Sponsored by Bio-Techne
Site powered by Webvision Cloud